Iratumumab is a human monoclonal antibody that was investigated for treating oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.